Abstract
Objective: This research aimed to evaluate the prognostic value of serum serum Cortisol, TNF-α, albumin in selecting treatment methods for advanced ovarian cancer (OC) patients.
Methods: A retrospective analysis was conducted on OC patients undergoing surgery at our hospital from June 2022 to June 2024 with complete clinical and pathological data. Patients were categorized into low ALB (< 35 g/L) and normal ALB (≥ 35 g/L) groups based on pretreatment serum ALB levels. Each group was further divided into primary debulking surgery (PDS) and neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) subgroups. Clinicopathologic characteristics were analyzed.
Results: Pretreatment serum ALB levels positively correlated with progression-free survival (PFS) (r = 0.2989, P < 0.05) and overall survival (OS) (r = 0.2702, P < 0.05), with the low ALB group exhibiting significantly lower PFS and OS (P < 0.05). In the low ALB group, significant differences were observed between PDS and NACT-IDS in ascitic fluid level, R0 cytoreduction rate, postoperative complications, and length of stay (P < 0.05), though PFS and OS were comparable (P > 0.05). Similarly, in the normal ALB group, significant differences were noted in FIGO staging, ascitic fluid level, hemoglobin (HGB) levels, intraoperative hemorrhage, blood transfusion volume, R0 cytoreduction rate, and length of stay (P < 0.05), while PFS and OS remained unaffected by treatment type (P > 0.05). Additionally, C-reactive protein (CRP) levels were significantly higher in the low ALB group (6.5 ± 1.1 mg/L vs. 5.2 ± 1.0 mg/L, P < 0.05), indicating greater inflammation, whereas HGB levels were significantly lower (110.4 ± 15.8 g/L vs. 118.7 ± 10.5 g/L, P = 0.021), reflecting poorer nutritional status. Tumor necrosis factor-alpha (TNF-α) levels showed a non-significant upward trend (P = 0.058), while cortisol levels were similar between groups (P = 0.073).
Conclusion: Selecting NACT-IDS for advanced OC patients with hypoalbuminemia can reduce incidence of postoperative complications and elevate cytoreductive effect. Thus, hypoalbuminemia can serve as a reference indicator for advanced OC patients to choose NACT-IDS.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.